2026-至今 中國科學(xué)院廣州生物醫(yī)藥與健康研究院 研究員
2021-2025?中國科學(xué)院廣州生物醫(yī)藥與健康研究院 副研究員
2018 -2020 中國科學(xué)院廣州生物醫(yī)藥與健康研究院 博士后
2015- 2018 廣州醫(yī)科大學(xué)/呼吸疾病全國重點(diǎn)實驗室 博士
2011-2015 中國科學(xué)院廣州生物醫(yī)藥與健康研究院 研究實習(xí)員/助理研究員
2008-2011 沈陽藥科大學(xué)/軍事醫(yī)學(xué)科學(xué)院生物工程研究所 碩士
2004-2008 山東第一醫(yī)科大學(xué) 學(xué)士
1. 黏膜免疫與疫苗
2.艾滋病的免疫調(diào)控與功能治愈
1. 國家科技重大專項，2025ZD01905300，2026-2028，任務(wù)負(fù)責(zé)人
2. 國家自然科學(xué)基金集成項目，92569303，2026-2029，子課題負(fù)責(zé)人
3. 國家自然科學(xué)基金重點(diǎn)支持項目，92269201，2023-2026，子課題負(fù)責(zé)人
4. 國家自然科學(xué)基金面上項目，32370171，2024-2027，負(fù)責(zé)人
5. 國家自然科學(xué)基金青年項目，32000124，2021-2023，負(fù)責(zé)人
6. 廣州國家實驗室攻關(guān)項目，EKPG21-30-3，2021-2023，子課題負(fù)責(zé)人
7. 中國博士后特別資助項目，2020T130115ZX，2018-2020，負(fù)責(zé)人
8. 中國博士后基金面上項目，2019M663140，2018-2020，負(fù)責(zé)人
9. 廣東省自然科學(xué)基金面上項目，2021A1515010456，2021-2023，負(fù)責(zé)人
10. 中國科學(xué)院青促會項目，2022361，2022-2025，負(fù)責(zé)人
完整論著列表：https://pubmed.ncbi.nlm.nih.gov/?term=pingchao+li
#共同第一作者，*通訊作者
1.?He Y, Wu C, Feng F, Liu Z, Zhang X, Yang Q, Chen Z, Shi M, Wen Z, Liu Y, Hu F, Li L*, Sun C*, Chen L*, Li P*. 2025. Immune Control of AIDS Progression by an Adenovirus-Based Therapeutic Vaccination in Acute Simian Immunodeficiency Virus-Infected Macaques. MedComm 6:e70309.??
2.?Feng Y, Shu T, Li L, Sun X, Yu C, Liu W, Hong L, Li J, Zhao S, Zeng W, Yang C, Wang C, Zheng X, Ye X, Sun X, Liu Y, Li Z, Chen S, Niu X, Zhou R, Li P*, Feng L*, Chen L*. 2025. A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses. Mol Ther S1525-0016(25)01050-0.
3.?Chen S, Zhang Z, Lin Z, Yin L, Ning L, Liu W, Wang Q, Yang C, Feng B, Feng Y, Wang Y, Li H, He P, Liang H, Liu Y, Li Z, Liu B, Li Y, Boraschi D, Qu L, Niu X*, Zhong N*, Li P*, Chen L*. 2025. Intranasal booster drives class switching and homing of memory B cells for mucosal IgA response. JCI Insight e198045.
4.?Wen Z#, Li P#, Yuan Y#, Wang C#, Li M, Wang H, Shi M, He Y, Cui M, Chen L, Sun C. 2024. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques. Elife 13:RP95964
5.?Li H, Yang C, Yin L, Liu W, Zhang Z, Liu B, Sun X, Liu W, Lin Z, Liu Z, He P, Feng Y, Wang C, Wang W, Guan S*, Wang Q*, Chen L*, Li P*. 2024. Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants. Emerg Microbes Infect 13:2387447
6.?Chen S, Zhang Z, Wang Q#, Yang Q#, Yin L, Ning L, Chen Z, Tang J, Deng W, He P, Li H, Shi L, Deng Y, Liu Z, Bu H, Zhu Y, Liu W, Qu L, Feng L, Xiong X, Sun B, Zhong N, Li F, Li P*, Chen X*, Chen L*. 2024. Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies. Signal Transduct Target Ther 9:190.
7.?Li P#*, Wang Q#, He Y#, Yang C#, Zhang Z, Liu Z, Liu B, Yin L, Cui Y, Hu P, Liu Y, Zheng P, Wang W, Qu L, Sun C, Guan S, Feng L*, Chen L*. 2023. Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques. Emerg Microbes Infect 12:e2136538.
8.?Wang Q#, Yang C#, Yin L#, Sun J#, Wang W#, Li H, Zhang Z, Chen S, Liu B, Liu Z, Shi L, Liu X, Guan S, Wang C, Qu L, Feng Y, Niu X, Feng L, Zhao J*, Li P*, Chen L*, Zhong N. 2023. Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants. Signal Transduct Target Ther 8:167.
9.?Jie F, Wu X, Zhang F, Li J, Liu Z, He Y, Li C, Zhang H, Lin Y, Zhu X, Yu H, Liu Y, Li Z, Qu L*, Chen L*, Li P*. 2023. Influenza Virus Infection Increases Host Susceptibility To Secondary Infection with Pseudomonas aeruginosa, and This Is Attributed To Neutrophil Dysfunction through Reduced Myeloperoxidase Activity. Microbiol Spectr 11:e0365522.
10.?He Y, Wu C, Liu Z, Zhang Y, Feng F, Lin Z, Wang C, Yang Q, Wen Z, Liu Y, Zhang F, Lin Y, Zhang H, Qu L, Li L, Cai W, Sun C*, Chen L*, Li P*. 2023. Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques. Microbiol Spectr 11:e0052523.
11.?Liu W, Li H, Liu B, Lv T, Yang C, Chen S, Feng L, Lai L, Duan Z, Chen X, Li P*, Guan S*, Chen L*. 2023. A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine. Emerg Microbes Infect 12:2233643.
12.?Wang H#, Li P#, Zhang M, Bi J, He Y, Li F, Yu R, Gao F, Kong W, Yu B, Chen L, Yu X. 2022. Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques. Microb Biotechnol 15:2022-2039
13.?Wu C, He Y, Zhao J, Luo K, Wen Z, Zhang Y, Li M, Cui Y, Liu Z, Wang C, Han Z, Li G, Feng F, Li P*, Chen L*, Sun C*. 2021. Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption. J Virol 96:e0178521
14.?Wu C, Zhao J, Li R, Feng F, He Y, Li Y, Huang R, Li G, Yang H, Cheng G, Chen L, Ma F, Li P*, Sun C*. 2021. Modulation of Antiviral Immunity and Therapeutic Efficacy by 25-Hydroxycholesterol in Chronically SIV-Infected, ART-Treated Rhesus Macaques. Virol Sin 36(5):1197-1209
15.?Yan Q#, Li P#, Ye X#, Huang X#, Feng B, Ji T, Chen Z, Li F, Zhang Y, Luo K, Chen F, Mo X, Wang J, Feng L, Hu F, Lei C, Qu L, Chen L. 2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients. J Immunol 206:2146-2159.
16.?Yang Q#, Feng F#, Li P#, Pan E, Wu C, He Y, Zhang F, Zhao J, Li R, Feng L, Hu F, Li L, Zou H, Cai W, Lehner T, Sun C, Chen L. 2019. Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV-Infected Macaques. Adv Sci 6:1900319.
17.?Zhang F, Wang L, Niu X, Li J, Luo J, Feng Y, Yang Y, He P, Fan W, Liang R, Zheng Z, Pan W, Li C, Tan YJ, Yu H, Chen L*, Li P*. 2019. Phenotypic Characterization of Chinese Rhesus Macaque Plasmablasts for Cloning Antigen-Specific Monoclonal Antibodies. Front Immunol 10:2426.
18.?Li P, Feng F, Pan E, Fan X, Yang Q, Guan M, Chen L, Sun C. 2018. Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection. Virology 519:86-98.
